July 21, 2026

Tags :moderna

Moderna’s Flu Vaccine Win: The Unseen Costs of Regulatory Interference

Arjun Vedanta June 20, 2026

The Regulatory Gauntlet: Science vs. Politics A 9-0 vote for a new vaccine might sound like the purest form of scientific consensus, a triumph of data over doubt. But when the FDA’s advisory committee Read More

Artificial Intelligence

Moderna’s Ebola Vaccine Funding: A Public Risk, Private Reward Blueprint

Arjun Vedanta June 2, 2026

The Price of Platform Agility Fifty million dollars just landed in Moderna’s accounts, courtesy of the Coalition for Epidemic Preparedness Innovations (CEPI), earmarked for the early-stage development of an mRNA vaccine against Bundibugyo ebolavirus. Read More

Tags :moderna

Moderna’s Flu Vaccine Win: The Unseen Costs of Regulatory Interference

Moderna’s Ebola Vaccine Funding: A Public Risk, Private Reward Blueprint

Follow us: